Biocon Inc.

“Part vi, question 1a - the board of directors has nine members and two non-voting directors emeritus.”

“Members of the audit committee of the board of directors were provided with a paper copy of form 990. The 990 was reviewed at an open meeting of the audit committee. Subsequent to modifications, if any, as a result of the meeting, the 990 is circulated to all of the members of the board of directors for their final review and approval before filing.”

“Biocon operates under the conflict of interests policy of its related organization, mtf. Mtf employs the following procedures to monitor conflicts of interests. Mtf sends a comprehensive questionnaire annually to board members, officers and key employees requesting disclosure of any conflicts of interest. Mtf is diligent in reviewing the annual disclosure forms submtted by the covered persons, and in screening compiling and maintaining the submissions.”

“The ceo receives no compensation for duties associated with biocon, inc. And related disregarded entities. He is paid by mtf, a related organization. See schedule j, supplemental information, for additional information.”

“The treasurer and secretary receive no compensation for duties related to biocon, inc. And related disregarded entities. They are paid by mtf, a related organization. See schedule j, supplemental information, for additional information.”

“Biocon makes its form 990 and other public documents available to the public at its regular place of business in person, requests through email or via us postal service. In addition form 990 is available on the internet at www.guidestar.org.”

“Part vii - board of directors compensation - the board of directors receives no compensation from biocon for its activities. The board members are paid honorariums and reimbursed for reasonable travel costs associated with board meetings by mtf. Part vii - average hours per week joint meetings with the board of mtf are held to facilitate greater integration of governance oversight and to review issues and matters of common concern. Accordingly, no hours are noted for biocon but rather noted as hours for a related organization (mtf).”

“Biocon, inc. (bio) was formed to serve as the sole voting member of, and act as the holding company for, the musculoskeletal transplant foundation inc., (mtf) a non-profit 501(c) organization and deutsches institut fur zell-und gewebeersatz gmbh, (dizg) a german non-profit organization. Mtf's mission is to provide quality allograft tissues for transplantation, research and education. Dizg specializes in culturing and distribution of keratinocytes, musculoskeletal, and other tissue forms. Bio, as holding company, has authority to approve fundamental amendments to organizational documents and to approve certain corporate transactions such as mergers and dissolutions. Bio also has the exclusive right to elect or appoint all members of the board of directors of mtf and dizg. Bio continues to monitor and guide the activities of mtf and dizg, as well as any affiliates that may be formed or acquired in the future, to foster the provision of high quality human allograft tissue to the community through the most economical and efficient system possible.”

“Form 990, part iv, questions 14a and 14b - biocon, inc notes that it answered "no" to form 990, part iv, question 14a and 14b because its only international activity consists of dizg activity. 2021 activity for dizg is summarized on form 5471.”

“GERMANY”